Improved Biological Activity and Stability of enzyme L-Asparaginase in Solid Lipid Nanoparticles Formulation
Controlled release formulation of L-Asparaginase
Abstract
To protect the biological activity of an enzyme during the development of formulations is one of the biggest challenges. The tetrameric form of L-Asparaginase is used to treat Acute Lymphocytic Leukaemia. It possesses shorter in vivo half–life. Using a modified (water/oil)/water-emulsion method followed by solvent evaporation L-Asn was successfully encapsulated at the core of Solid Lipid Nanoparticles made of lipid glyceryl monostearate. This study elucidated that the preparation of L-Asn loaded SLN develop a colloidal formulation with enhanced activity. The in-vitro release profile of the enzyme revealed first bursts has been increased. The study of the lyophilised formulation also shows that the enzyme holds its biological activity and retains its particle size distribution. Consequently, by using an apt combination of homogenisation speed, temperature and additives the storage and biological activity of L-Asn in SLN formulation can be improved.
Keywords: L-Asparaginase, Solid Lipid Nanoparticles, Controlled release, Lymphocytic Leukaemia
DOI
https://doi.org/10.22270/jddt.v9i2-s.2708References
Müller H.J., Boos J., Use of l-asparaginase in childhood ALL,. Critical. Review of Oncology, Haematology, 1998; 28:97–113
Cappizzi RL, Powell BL, Cooper MR, Stuart JJ, Muss HB, Richards F, Jackson DV et al, Sequential high-dose Ara-C and asparaginase in the therapy of previously treated and untreated patients with acute leukemia, Semin. Oncology 1985; 12:105–113.
Clarkson B, Krakoff Y, Burchenal J, Karnofsky D, Golbey R, Dowling M, Oettgen H, A. Lipton, Clinical results of treatment with E. coli L-asparaginase in adults with leukaemia, lymphoma, and solid tumors, Cancer, 1970; 25:279–305.
Cruz M.E.M., Gaspar M.M., Lopes F., Jorge J.S., Perez- Soler R., Liposomal L-Asparaginase: in vitro evaluation, International Journal of Pharmacy, 1993; 96:67–77.
Gaspar MM, Perez-Soler R, Cruz M.E.M., Biological characterization of L-asparaginase liposomal formulations, Cancer Chemotherapy and. Pharmacology, 1996; 38:373–377.
Neerunjun D, Gregoriadis G, Tumor regression with liposome-entrapped asparaginase: some immunological advantages, Biochemical Society Transactions, 1976; 4:133–134.
Ertl B., Gusenbauer C., Kudrnac M., Wirth M., Gabor F., Evaluation of the characteristics of protein-loaded poly(d,l-lactide-co-glycolide) nanospheres by preparation according to a central composite design. Scientia Pharmaceutica, 1999; 67, 289–304.
Wriston JC, Yellin TO, L-asparaginase, Advanced Enzymology, 1973; 39:185–248
Stecher A.L., de Deus P.M., Polikarpov, I., Abrahao-Neto, J., Stability of l-asparaginase: An enzyme used in leukaemia treatment, Pharmaceutica Acta Helvetiae, 1999; 74:1–9.
Sharif, S., O’Hagan, D.T., A comparison of alternative methods for the determination of the levels of proteins entrapped in poly(lactide-co-glycolide) microparticles. International Journal of Pharmaceutics, 1995; 115:259–263.
Gaspar M.M., Blanco D., Cruz M.E.M., Alonso M.J., Formulation of L-asparaginase-loaded PLGA Nanoparticles: Influence of polymer properties on enzyme loading, activity and in vitro release. Journal of Controlled Release, 1998; 52:53–62.
Diwan M., Park T.G., PEGylation enhances protein stability during encapsulation in PLGA microspheres. Journal of Controlled Release 2001; 73:233–244.
Published
Abstract Display: 817 
PDF Downloads: 682 How to Cite
Issue
Section
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0). that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
How to Cite
.